Neutralization and antibody-dependent enhancement of dengue viruses

SB Halstead - Adv virus res, 2003 - books.google.com
SB Halstead
Adv virus res, 2003books.google.com
B. Number of Antibody Molecules Required to Neutralize Dengue Viruses C. Data from
Monoclonal Antibody Studies: Ratio between NT and Antibody-Dependent Enhancement
(ADE) D. Measuring Neutralizing Antibodies in Vitro Antibody-Dependent Enhancement:
Clinical and Epidemiological Evidence of Immunologically Enhanced Disease A. Dengue
Hemorrhagic Fever (DHF)/Dengue Shock Syndrome (DSS) Is Associated with Heterotypic
Dengue Infections DHF Occurs with Passively Acquired Dengue Antibodies DHF in …
B. Number of Antibody Molecules Required to Neutralize Dengue Viruses C. Data from Monoclonal Antibody Studies: Ratio between NT and Antibody-Dependent Enhancement (ADE) D. Measuring Neutralizing Antibodies in Vitro Antibody-Dependent Enhancement: Clinical and Epidemiological Evidence of Immunologically Enhanced Disease A. Dengue Hemorrhagic Fever (DHF)/Dengue Shock Syndrome (DSS) Is Associated with Heterotypic Dengue Infections DHF Occurs with Passively Acquired Dengue Antibodies DHF in Prospective Seroepidemiological Studies Factors Controlling Illness Severity during Secondary Infections Factors Controlling Illness Severity during Primary Infections in the Presence of Passively Acquired Antibody V. Viral Factors
books.google.com